<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Therapy-related <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) is mostly attributed to chemotherapeutic agents of <z:chebi fb="0" ids="22333">alkylating agents</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Few studies have evaluated the late effects of chemotherapy for <z:hpo ids='HP_0002861'>malignant melanoma</z:hpo> (MM) </plain></SENT>
<SENT sid="2" pm="."><plain>To evaluate whether <z:chebi fb="0" ids="4305">dacarbazine</z:chebi>, <z:chebi fb="0" ids="7576">nimustine hydrochloride</z:chebi> and <z:chebi fb="0" ids="28445">vincristine</z:chebi> <z:chebi fb="0" ids="16189">sulfate</z:chebi> (DAV) therapy for MM related to t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> or not, a retrospective analysis was performed </plain></SENT>
<SENT sid="3" pm="."><plain>We conducted a retrospective case-control study in a cohort of the 217 patients diagnosed with MM from 1989-2007 in Aichi Medical University Department of Dermatology and Nagoya University Graduate School of Medicine Department of Dermatology </plain></SENT>
<SENT sid="4" pm="."><plain>One hundred and fifty-five of the 217 patients with MM were prospectively followed after DAV therapy or with or without local injection of Î²-interferon, of whom two patients developed t-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Cytogenetic abnormalities were found in two of the 35 patients by chromosome banding method - <z:hpo ids='HP_0001909'>leukemia</z:hpo> (G-Banding) </plain></SENT>
<SENT sid="6" pm="."><plain>The karyotypes were found in the chromosome of -5, deletion (5), addition (7) and 7q- </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, DAV therapy should be used carefully for older patients with MM after satisfactory operation </plain></SENT>
</text></document>